|
 |
|
|||||||
|
|||||||||
Correspondence to:
Neil S. Shachter
Apolipoprotein (apo) C-I is a constituent of triglyceride-rich lipoproteins (TGRL) that interferes with their hepatic clearance. Functional polymorphism in the apoC-I gene has not been established. We determined that an Hpa I site variably present at -317 relative to the apoC-I gene is produced by a 4-bp CGTT insertion. The apoC-I Hpa I alleles showed an ethnically distinct pattern of linkage disequilibrium with the alleles of the adjacent apoE gene. The frequency of apoC-I Hpa I-positive (H2) with apoE
Supplementary key words:
apolipoproteins C, apolipoproteins E, apolipoproteins B, biochemical genetics, genotype, VLDL
Copyright © 1999 by Lipid Research, Inc.
Original Article
A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E
Yan Xua,
Lars Berglunda,
Rajasekhar Ramakrishnanc,
Richard Mayeuxb,
Colleen Ngaia,
Steven Holleranc,
Benjamin Tyckod,
Todd Leffe, and
Neil S. Shachtera
a Division of Preventive Medicine and Nutrition, Department of Medicine, College of Physicians and Surgeons of Columbia University, 630 W. 168th Street, New York, NY 10032
b Gertrude H. Sergievsky Center and Department of Neurology, College of Physicians and Surgeons of Columbia University, 630 W. 168th Street, New York, NY 10032
c Department of Pediatrics, College of Physicians and Surgeons of Columbia University, 630 W. 168th Street, New York, NY 10032
d Department of Pathology, College of Physicians and Surgeons of Columbia University, 630 W. 168th Street, New York, NY 10032
e Department of Biological Chemistry, University of Michigan and Department of Cell Biology, Parke-Davis Pharmaceuticals, 2800 Plymouth Road, Ann Arbor, MI 48106
2 was 0.98, without significant ethnic difference. In contrast, the frequency of H2 with apoE 4 was 0.85 in European-Americans but only 0.55 in African-Americans (P < 0.001). The frequency of H2 with apoE 3 was 0.02 in European-Americans and 0.08 in African-Americans (P < 0.001). African-American apoE 3/3 carriers of apoC-I H2 had 19% lower fasting triglyceride levels than H1 homozygotes (P = 0.03) along with 18% higher HDL-cholesterol levels (P = 0.02). ApoB levels were 21% lower (P = 0.002). H2-allelic reporter-gene constructions showed 50% higher expression in transient transfection studies. We localized the source of this difference in expression to the CGTT insertion itself. Deletion studies of the H1 allele showed a negative transcriptional effect of the polymorphic region. An H1 oligodeoxynucleotide showed specific binding of a hepatoma-cell nuclear protein not evident with an H2 oligodeoxynucleotide. The H2 sequence may decrease the binding of a negatively acting transcription factor, leading to overexpression of apoC-I. This may produce a functional effect on lipoprotein levels but confirmation is needed in other populations.—Xu, Y., L. Berglund, R. Ramakrishnan, R. Mayeux, C. Ngai, S. Holleran, B. Tycko, T. Leff, and N. S. Shachter. A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J. Lipid Res. 1999. 40: 50–58. 
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  W.-L. Chuang, Y.-C. Hsieh, C.-Y. Wang, H.-C. Kuo, and C.-C. Huang Association of Apolipoproteins E4 and C1 With Onset Age and Memory: A Study of Sporadic Alzheimer Disease in Taiwan J Geriatr Psychiatry Neurol, March 1, 2010; 23(1): 42 - 48. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Anuurad, M. Yamasaki, N. Shachter, T. A. Pearson, and L. Berglund ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans J. Lipid Res., July 1, 2009; 50(7): 1472 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Abildayeva, J. F. P. Berbee, A. Blokland, P. J. Jansen, F. J. Hoek, O. Meijer, D. Lutjohann, T. Gautier, T. Pillot, J. De Vente, et al. Human apolipoprotein C-I expression in mice impairs learning and memory functions J. Lipid Res., April 1, 2008; 49(4): 856 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Ewbank Differences in the Association Between Apolipoprotein E Genotype and Mortality Across Populations J Gerontol A Biol Sci Med Sci, August 1, 2007; 62(8): 899 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Westerterp, W. de Haan, J. F. P. Berbee, L. M. Havekes, and P. C. N. Rensen Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL J. Lipid Res., June 1, 2006; 47(6): 1203 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. O. Kwiterovich Jr, S. L. Cockrill, D. G. Virgil, E. S. Garrett, J. Otvos, C. Knight-Gibson, P. Alaupovic, T. Forte, L. Zhang, Z. N. Farwig, et al. A Large High-Density Lipoprotein Enriched in Apolipoprotein C-I: A Novel Biochemical Marker in Infants of Lower Birth Weight and Younger Gestational Age JAMA, April 20, 2005; 293(15): 1891 - 1899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. P. Berbee, C. C. van der Hoogt, D. Sundararaman, L. M. Havekes, and P. C. N. Rensen Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL J. Lipid Res., February 1, 2005; 46(2): 297 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pastinen and T. J. Hudson Cis-Acting Regulatory Variation in the Human Genome Science, October 22, 2004; 306(5696): 647 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Tycko, J. H. Lee, A. Ciappa, A. Saxena, C.-M. Li, L. Feng, A. Arriaga, Y. Stern, R. Lantigua, N. Shachter, et al. APOE and APOC1 Promoter Polymorphisms and the Risk of Alzheimer Disease in African American and Caribbean Hispanic Individuals Arch Neurol, September 1, 2004; 61(9): 1434 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bjorkegren, A. Silveira, S. Boquist, R. Tang, F. Karpe, M. G. Bond, U. de Faire, and A. Hamsten Postprandial Enrichment of Remnant Lipoproteins With ApoC-I in Healthy Normolipidemic Men With Early Asymptomatic Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2002; 22(9): 1470 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yoshida, N. Hamajima, K.-i. Kozaki, H. Saito, K. Maeno, T. Sugiura, K. Ookuma, and T. Takahashi Association between the Dopamine D2 Receptor A2/A2 Genotype and Smoking Behavior in the Japanese Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 403 - 405. [Abstract] [Full Text]
|
|
|
|
|
|
D. M. Waterworth, J. A. Hubacek, J. Pitha, J. Kovar, R. Poledne, S. E. Humphries, and P. J. Talmud Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI;-APOE cluster J. Lipid Res., July 1, 2000; 41(7): 1103 - 1109. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |